Julitam/Julitam I.V. Indications/Uses

Julitam: Tablet: For monotherapy and adjunctive treatment of partial seizures with or without secondary generalization and for adjunctive therapy of myoclonic seizures and primarily generalized tonic clonic seizures.
Oral solution: Levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.
Levetiracetam is indicated as adjunctive therapy: In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 1 month of age with epilepsy.
In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.
In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.
Levetiracetam Oral Solution concentrate is an alternative for patients (adults and children from 4 years of age) when oral administration is temporarily not feasible.
Julitam I.V.: It is used as an alternative for patients when oral administration is temporarily not feasible: as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalization in adults and children from 4 years of age; in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy; in the treatment of primary generalized tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalized Epilepsy; as monotherapy in the treatment of partial onset seizures with or without secondary generalization in patients from 16 years of age.